Fatty Liver is India's Silent Epidemic: Can AI Blood Test Screening Cut Costs from Thousands of Rupees to a Few Hundred?
Fatty liver disease is emerging as a growing public health concern in India, with many people potentially living with the condition without knowing it. Often, the disease develops silently, showing few or no noticeable symptoms in its early stages. It is frequently detected during routine health check ups or when people undergo investigations for other health conditions.
However, identifying fatty liver is only part of the challenge. Routine liver function tests do not always detect early disease or identify people who may be at risk of developing liver fibrosis, a condition in which healthy liver tissue is gradually replaced by scar tissue. As the burden of obesity, diabetes and other metabolic disorders continues to grow, the need for accessible and affordable screening is becoming increasingly important.
Unlock the Future of Digital Health — Free for 14 Days!
Join DHN Plus and access exclusive news, intelligence reports, and deep-dive research trusted by healthtech leaders.
Already a subscriber? Log in
Start with 14-Days Free TrialStay tuned for more such updates on Digital Health News
Follow us
